CRISPR 2.0: a new wave of gene editors heads for clinical trials

37Report
CRISPR 2.0: a new wave of gene editors heads for clinical trials

Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.

Similar news

Share
Report

Report this article here.